98%
921
2 minutes
20
Psychoactive drugs in fish act through mechanisms similar to those in humans because their main neurotransmitter (NT) systems are analogous. Psychoactive drugs are ubiquitous in aquatic environments, having negative effects on fish and other aquatic organisms. To understand the neurochemical changes underlying the effects, studying neurotransmitter levels is essential. The detection of NTs and their metabolites in biological samples may be challenging. A new analytical method using hydrophilic interaction liquid chromatography coupled to high-resolution mass spectrometry was developed. The method includes simple extraction and 17 min analytical run and enables reliable quantification of a wide range of NTs from different classes, including their precursors and metabolites: acetylcholine, choline, citrulline, 3,4-dihydroxyphenylacetic acid, dopamine, dopamine-3-O-sulfate, epinephrine, gamma-aminobutyric acid, gamma-hydroxybutyric acid, glutamate, glutamine, α-glycerophosphorylcholine, guanidine, histamine, histidine, levodopa, melatonin, norepinephrine, normetanephrine, octopamine, phenylalanine, phosphocholine, serotonin, 5-hydroxyindoleacetic acid, synephrine, tryptophan, 5-hydroxytryptophan, tyramine, 3-methoxytyramine, and tyrosine. The method was validated with highly satisfying performance parameters regarding sensitivity, repeatability and trueness. Under optimized conditions, recoveries from 55 to 130 % were obtained, while intra-day and inter-day RSD never exceeded 24 and 29 %, respectively. LOQs between 0.0012 and 25 μg/g d.w. were achieved. Finally, the optimized method was applied to analyze NTs in the brains of two fish species: European perch and rainbow trout. Proposed method will help to obtain fundamental information on NTs content in fish brain and on their changes in response to the exposure to psychoactive drugs.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.envpol.2025.127031 | DOI Listing |
J Med Internet Res
September 2025
School of Pharmacy, Sungkyunkwan University, Gyeonggi-do, Republic of Korea.
Background: Owing to the unique characteristics of digital health interventions (DHIs), a tailored approach to economic evaluation is needed-one that is distinct from that used for pharmacotherapy. However, the absence of clear guidelines in this area is a substantial gap in the evaluation framework.
Objective: This study aims to systematically review and compare the economic evaluation literature on DHIs and pharmacotherapy for the treatment of depression.
Metab Brain Dis
September 2025
Department of Neuroscience, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran.
Brain ischemia is a major global cause of disability, frequently leading to psychoneurological issues. This study investigates the effects of 4-aminopyridine (4-AP) on anxiety, cognitive impairment, and potential underlying mechanisms in a mouse model of medial prefrontal cortex (mPFC) ischemia. Mice with mPFC ischemia were treated with normal saline (NS) or different doses of 4-AP (250, 500, and 1000 µg/kg) for 14 consecutive days.
View Article and Find Full Text PDFNed Tijdschr Geneeskd
September 2025
LUMC, Leiden, afd. Psychiatrie.
Agitated patients present a challenge in clinical practice. Management strategies vary depending on severity, ranging from (non-)verbal de-escalation to pharmacological sedation. This article outlines a stepwise approach to treating agitation, distinguishing between mild, moderate, and extreme agitation.
View Article and Find Full Text PDFNat Commun
September 2025
Institute of Neurosciences and Medicine, Brain & Behaviour (INM-7), Research Centre Juelich; Wilhelm-Johnen-Straße 1, Juelich, Germany.
Autism is a neurodevelopmental condition associated with altered resting-state brain function. An increased excitation-inhibition ratio is discussed as a pathomechanism but in-vivo evidence of disturbed neurotransmission underlying functional alterations remains scarce. We compare local resting-state brain activity and neurotransmitter co-localizations between autism (N = 405, N = 395) and neurotypical controls (N = 473, N = 474) in two independent cohorts and correlate them with excitation-inhibition changes induced by glutamatergic (ketamine) and GABAergic (midazolam) medication.
View Article and Find Full Text PDFNat Commun
September 2025
CReATe Fertility Centre, Toronto, ON, Canada.
Cannabis consumption and legalization is increasing globally, raising concerns about its impact on fertility. In humans, we previously demonstrated that tetrahydrocannabinol (THC) and its metabolites reach the ovarian follicle. An extensive body of literature describes THC's impact on sperm, however no such studies have determined its effects on the oocyte.
View Article and Find Full Text PDF